Edge Wealth Management’s Accelerate Diagnostics AXDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-100
Closed -$14K 483
2016
Q2
$14K Hold
100
0.01% 285
2016
Q1
$14K Hold
100
0.01% 255
2015
Q4
$21K Hold
100
0.01% 234
2015
Q3
$16K Buy
+100
New +$21.6K 0.01% 250

Other funds holding AXDX

Edge Wealth Management's AXDX Position: Q3 2016 in Review

Edge Wealth Management sold out of Accelerate Diagnostics (AXDX) in Q3 2016, closing a stake of 100 shares — an estimated $14K sold.

Edge Wealth Management first reported a position in AXDX in Q3 2015 and held it in 4 quarters. The position peaked at $21K in Q4 2015. 103 funds tracked by Wall St. Rank hold AXDX as of Q3 2016.

  • Edge Wealth Management reported no remaining Accelerate Diagnostics position as of Q3 2016 after selling out during the quarter.
  • Edge Wealth Management sold 100 Accelerate Diagnostics shares in Q3 2016, an estimated $14K.
  • Edge Wealth Management first reported a position in Accelerate Diagnostics in Q3 2015 and held it in 4 quarters.
  • Edge Wealth Management's Accelerate Diagnostics position peaked at $21K in Q4 2015.
  • 103 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2016.

Based on Edge Wealth Management's 13F filing for Q3 2016, filed 13 Oct 2016.